Expanding Lung Cancer Screening to Persons who do not Meet the 2021 USPSTF Guidelines Criteria: A Study from End Lung Cancer Now

J
Julian Marin Acevedo

Primary Investigator

Enrolling By Invitation
18 years - 100 years
All
Phase N/A
500 participants needed
2 Locations

Brief description of study

What is the purpose of this study?
The primary objective of this study is to estimate the proportion of individuals with lung cancer seen at Indiana University and Eskenazi Health Centers who do not meet the 2021 USPSTF criteria for lung cancer screening.
 
THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic. 
 
Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office 
Phone: (317) 278-5632

Detailed description of study

What will happen during the study?

  • This will be a prospective, observational study of all lung cancer patients seen in the thoracic (medical and surgical) oncology clinics at IUSCCC and Eskenazi Health.
  • Eligible individuals will complete a one-time, electronic survey assessing demographics, lung cancer screening eligibility, and pre-defined well-known risk factors for lung cancer.
  • A few additional datapoints in the survey will be collected by the staff directly from the EMR at any point after consent obtention. 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Lung Cancer
  • Age: 18 years - 100 years
  • Gender: All

Inclusion criteria:
• Patients with any histology of lung cancer with and any stage. 
• 18 years or older at the time of informed consent. 
• Patient resides in Indiana. 
• Patient should be able to understand English or Spanish to a level that allows completing a survey.

Updated on 26 Mar 2025. Study ID: CTO-IUSCCC-0876, 25048
Please visit our main page to search for other studies you may be interested in. If you need help finding a study or have any questions, please contact us at inhealth@iu.edu

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center